30 years of CIK cell therapy: recapitulating the key breakthroughs and future perspective

Emerging evidence from the numerous clinical trials involving cytokine-induced killer (CIK) cell therapy suggests that its optimization in combination with other contemporary cancer therapies in a complementary manner (rather than as competition) will be a key to combat cancer.

Saved in:
Bibliographic Details
Published in:Journal of experimental & clinical cancer research Vol. 40; no. 1; p. 388
Main Authors: Sharma, Amit, Schmidt-Wolf, Ingo G H
Format: Journal Article
Language:English
Published: England BioMed Central Ltd 09-12-2021
BioMed Central
BMC
Subjects:
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Abstract Emerging evidence from the numerous clinical trials involving cytokine-induced killer (CIK) cell therapy suggests that its optimization in combination with other contemporary cancer therapies in a complementary manner (rather than as competition) will be a key to combat cancer.
AbstractList Emerging evidence from the numerous clinical trials involving cytokine-induced killer (CIK) cell therapy suggests that its optimization in combination with other contemporary cancer therapies in a complementary manner (rather than as competition) will be a key to combat cancer.
Abstract Emerging evidence from the numerous clinical trials involving cytokine-induced killer (CIK) cell therapy suggests that its optimization in combination with other contemporary cancer therapies in a complementary manner (rather than as competition) will be a key to combat cancer.
Emerging evidence from the numerous clinical trials involving cytokine-induced killer (CIK) cell therapy suggests that its optimization in combination with other contemporary cancer therapies in a complementary manner (rather than as competition) will be a key to combat cancer. Keywords: Cytokine-induced killer (CIK) cell therapy, Immunotherapies
ArticleNumber 388
Audience Academic
Author Schmidt-Wolf, Ingo G H
Sharma, Amit
Author_xml – sequence: 1
  givenname: Amit
  orcidid: 0000-0002-2216-5389
  surname: Sharma
  fullname: Sharma, Amit
  organization: Department of Neurosurgery, University Hospital Bonn, 53127, Bonn, Germany
– sequence: 2
  givenname: Ingo G H
  surname: Schmidt-Wolf
  fullname: Schmidt-Wolf, Ingo G H
  email: Ingo.Schmidt-Wolf@ukbonn.de
  organization: Department of Integrated Oncology, Center for Integrated Oncology (CIO), University Hospital Bonn, 53127, Bonn, Germany. Ingo.Schmidt-Wolf@ukbonn.de
BackLink https://www.ncbi.nlm.nih.gov/pubmed/34886895$$D View this record in MEDLINE/PubMed
BookMark eNptkkuLFDEUhQsZcR76B1xIgSBuasy7ExfC0PhoHHCjC1chnbpVlZ7qSpmkBvrfm-oex26REHK5-c4JuZzL4mzwAxTFS4yuMZbiXcQUMVEhguctWUWeFBd4wUWllBBnR_V5cRnjBiGBFVbPinPKpBRS8YviJ0XlDkyIpW_K5epraaHvy9RBMOPufRnAmtGlqTfJDe3cL-9gV64DmLvUBT-1XSzNUJfNlKYA5QghjmCTu4fnxdPG9BFePJxXxY9PH78vv1S33z6vlje3leWKpYrTmnOJpQVFrLIEM85tjYE20NBGLQxWChlrKKasFgu0IAgEzmWTGYYRvSpWB9_am40eg9uasNPeOL1v-NBqE5KzPWhmG2wwNowhxMCwtQQOFCmxloTnh7PXh4PXOK23UFsYUjD9ienpzeA63fp7LYUgUuJs8PbBIPhfE8Skty7OIzUD-ClqIpDkdIHRjL7-B934KQx5VJnCmHAiufxLtSZ_wA2Nz-_a2VTfCCkY4WxPXf-HyquGrbM5NY3L_RPBmyNBB6ZPXfT9lJwf4ilIDqANPsYAzeMwMNJzCvUhhTonUO9TqEkWvToe46PkT-zob64W1mk
CitedBy_id crossref_primary_10_1016_j_bbcan_2023_188905
crossref_primary_10_3389_fimmu_2023_1229540
crossref_primary_10_1016_j_ctrv_2023_102665
crossref_primary_10_3390_ijms23073783
crossref_primary_10_1186_s40164_024_00506_6
crossref_primary_10_1186_s40164_024_00507_5
crossref_primary_10_3389_fimmu_2022_956181
crossref_primary_10_1016_j_biopha_2022_113110
crossref_primary_10_1002_cti2_1500
crossref_primary_10_3389_fimmu_2022_925633
crossref_primary_10_1007_s10238_023_01177_z
crossref_primary_10_2217_epi_2023_0373
crossref_primary_10_3390_ijms24065626
crossref_primary_10_3389_fonc_2023_1157366
crossref_primary_10_3892_ol_2024_14334
crossref_primary_10_1186_s13046_024_02990_4
crossref_primary_10_1093_jleuko_qiad144
crossref_primary_10_3389_fonc_2022_713476
crossref_primary_10_3390_ijms23031311
crossref_primary_10_3390_biology11081174
crossref_primary_10_1007_s00262_023_03605_1
crossref_primary_10_1038_s41423_023_01031_y
crossref_primary_10_1016_j_biopha_2023_114732
crossref_primary_10_1007_s12032_023_02235_y
crossref_primary_10_2174_0109298673263335231121103807
crossref_primary_10_1186_s12943_023_01735_9
crossref_primary_10_3389_fimmu_2024_1268652
crossref_primary_10_3390_ijms241512476
Cites_doi 10.1084/jem.174.1.139
10.3390/ijms18050945
10.1136/jitc-2021-002475
10.3390/ijms19020358
10.3390/cancers12071818
10.1080/14712598.2020.1728250
10.3389/fimmu.2017.00774
10.1039/d0tb01391a
10.1016/j.cytogfr.2017.06.003
10.1002/jcp.29827
ContentType Journal Article
Copyright 2021. The Author(s).
COPYRIGHT 2021 BioMed Central Ltd.
2021. This work is licensed under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.
The Author(s) 2021
Copyright_xml – notice: 2021. The Author(s).
– notice: COPYRIGHT 2021 BioMed Central Ltd.
– notice: 2021. This work is licensed under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.
– notice: The Author(s) 2021
DBID CGR
CUY
CVF
ECM
EIF
NPM
AAYXX
CITATION
3V.
7X7
7XB
88E
8FI
8FJ
8FK
ABUWG
AFKRA
AZQEC
BENPR
CCPQU
DWQXO
FYUFA
GHDGH
K9.
M0S
M1P
PIMPY
PQEST
PQQKQ
PQUKI
PRINS
7X8
5PM
DOA
DOI 10.1186/s13046-021-02184-2
DatabaseName Medline
MEDLINE
MEDLINE (Ovid)
MEDLINE
MEDLINE
PubMed
CrossRef
ProQuest Central (Corporate)
ProQuest - Health & Medical Complete保健、医学与药学数据库
ProQuest Central (purchase pre-March 2016)
Medical Database (Alumni Edition)
Hospital Premium Collection
Hospital Premium Collection (Alumni Edition)
ProQuest Central (Alumni) (purchase pre-March 2016)
ProQuest Central (Alumni)
ProQuest Central UK/Ireland
ProQuest Central Essentials
ProQuest Databases
ProQuest One Community College
ProQuest Central
Health Research Premium Collection
Health Research Premium Collection (Alumni)
ProQuest Health & Medical Complete (Alumni)
Health & Medical Collection (Alumni Edition)
PML(ProQuest Medical Library)
Publicly Available Content Database
ProQuest One Academic Eastern Edition (DO NOT USE)
ProQuest One Academic
ProQuest One Academic UKI Edition
ProQuest Central China
MEDLINE - Academic
PubMed Central (Full Participant titles)
Directory of Open Access Journals
DatabaseTitle MEDLINE
Medline Complete
MEDLINE with Full Text
PubMed
MEDLINE (Ovid)
CrossRef
Publicly Available Content Database
ProQuest Central Essentials
ProQuest One Academic Eastern Edition
ProQuest Health & Medical Complete (Alumni)
ProQuest Central (Alumni Edition)
ProQuest One Community College
ProQuest Hospital Collection
Health Research Premium Collection (Alumni)
ProQuest Central China
ProQuest Hospital Collection (Alumni)
ProQuest Central
ProQuest Health & Medical Complete
Health Research Premium Collection
ProQuest Medical Library
ProQuest One Academic UKI Edition
Health and Medicine Complete (Alumni Edition)
ProQuest Central Korea
ProQuest One Academic
ProQuest Medical Library (Alumni)
ProQuest Central (Alumni)
MEDLINE - Academic
DatabaseTitleList MEDLINE


Publicly Available Content Database


CrossRef

Database_xml – sequence: 1
  dbid: DOA
  name: Directory of Open Access Journals
  url: http://www.doaj.org/
  sourceTypes: Open Website
– sequence: 2
  dbid: ECM
  name: MEDLINE
  url: https://search.ebscohost.com/login.aspx?direct=true&db=cmedm&site=ehost-live
  sourceTypes: Index Database
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
EISSN 1756-9966
EndPage 388
ExternalDocumentID oai_doaj_org_article_4cf1a11a44004ea4b8e5e3096b825145
A686425458
10_1186_s13046_021_02184_2
34886895
Genre Editorial
Commentary
GroupedDBID ---
-5E
-5G
-A0
-BR
0R~
29K
2WC
3V.
4.4
5GY
5VS
7X7
88E
8FI
8FJ
AAFWJ
AAJSJ
ABDBF
ABUWG
ACGFO
ACGFS
ACRMQ
ADBBV
ADINQ
ADRAZ
ADUKV
AENEX
AFKRA
AFPKN
AHBYD
AHMBA
AHYZX
ALIPV
ALMA_UNASSIGNED_HOLDINGS
AMKLP
AOIJS
BAWUL
BCNDV
BENPR
BFQNJ
BMC
BPHCQ
BVXVI
C24
C6C
CCPQU
CGR
CS3
CUY
CVF
D-I
DIK
DU5
E3Z
EBD
EBLON
EBS
ECM
EIF
ESX
F5P
FYUFA
GROUPED_DOAJ
HMCUK
HYE
IAO
IEA
IHR
IHW
INH
INR
ITC
KQ8
M1P
M48
M~E
NPM
O5R
O5S
OK1
P2P
PGMZT
PIMPY
PQQKQ
PROAC
PSQYO
RBZ
RNS
ROL
RPM
RSV
SMD
SOJ
TR2
TUS
UKHRP
~8M
AAYXX
CITATION
AFGXO
7XB
8FK
AZQEC
DWQXO
K9.
PQEST
PQUKI
PRINS
7X8
5PM
ID FETCH-LOGICAL-c594t-53d55818ce92c9c21455cd1e3fef3f97a1990aca3134d670720e614d6f1e34103
IEDL.DBID RPM
ISSN 1756-9966
0392-9078
IngestDate Tue Oct 22 15:12:56 EDT 2024
Tue Sep 17 21:27:51 EDT 2024
Fri Oct 25 02:54:04 EDT 2024
Thu Oct 10 16:30:43 EDT 2024
Tue Nov 19 21:05:45 EST 2024
Tue Nov 12 23:26:11 EST 2024
Tue Aug 20 22:11:39 EDT 2024
Fri Nov 22 14:51:47 EST 2024
Sat Sep 28 08:20:42 EDT 2024
IsDoiOpenAccess true
IsOpenAccess true
IsPeerReviewed true
IsScholarly true
Issue 1
Keywords Immunotherapies
Cytokine-induced killer (CIK) cell therapy
Language English
License 2021. The Author(s).
Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated in a credit line to the data.
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-c594t-53d55818ce92c9c21455cd1e3fef3f97a1990aca3134d670720e614d6f1e34103
Notes SourceType-Other Sources-1
content type line 63
ObjectType-Editorial-2
ObjectType-Commentary-1
ORCID 0000-0002-2216-5389
OpenAccessLink https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8662881/
PMID 34886895
PQID 2611252858
PQPubID 105475
PageCount 1
ParticipantIDs doaj_primary_oai_doaj_org_article_4cf1a11a44004ea4b8e5e3096b825145
pubmedcentral_primary_oai_pubmedcentral_nih_gov_8662881
proquest_miscellaneous_2608537101
proquest_journals_2611252858
gale_infotracmisc_A686425458
gale_infotracacademiconefile_A686425458
gale_healthsolutions_A686425458
crossref_primary_10_1186_s13046_021_02184_2
pubmed_primary_34886895
PublicationCentury 2000
PublicationDate 2021-12-09
PublicationDateYYYYMMDD 2021-12-09
PublicationDate_xml – month: 12
  year: 2021
  text: 2021-12-09
  day: 09
PublicationDecade 2020
PublicationPlace England
PublicationPlace_xml – name: England
– name: London
PublicationTitle Journal of experimental & clinical cancer research
PublicationTitleAlternate J Exp Clin Cancer Res
PublicationYear 2021
Publisher BioMed Central Ltd
BioMed Central
BMC
Publisher_xml – name: BioMed Central Ltd
– name: BioMed Central
– name: BMC
References X Gao (2184_CR7) 2017; 8
2184_CR8
E Cappuzzello (2184_CR10) 2017; 36
Y Zhang (2184_CR2) 2020; 235
2184_CR3
2184_CR5
2184_CR6
IG Schmidt-Wolf (2184_CR1) 1991; 174
S Wang (2184_CR4) 2020; 20
S Liang (2184_CR9) 2020; 8
References_xml – volume: 174
  start-page: 139
  year: 1991
  ident: 2184_CR1
  publication-title: J Exp Med
  doi: 10.1084/jem.174.1.139
  contributor:
    fullname: IG Schmidt-Wolf
– ident: 2184_CR8
  doi: 10.3390/ijms18050945
– ident: 2184_CR3
  doi: 10.1136/jitc-2021-002475
– ident: 2184_CR5
  doi: 10.3390/ijms19020358
– ident: 2184_CR6
  doi: 10.3390/cancers12071818
– volume: 20
  start-page: 601
  year: 2020
  ident: 2184_CR4
  publication-title: Expert Opin Biol Ther
  doi: 10.1080/14712598.2020.1728250
  contributor:
    fullname: S Wang
– volume: 8
  start-page: 774
  year: 2017
  ident: 2184_CR7
  publication-title: Front Immunol
  doi: 10.3389/fimmu.2017.00774
  contributor:
    fullname: X Gao
– volume: 8
  start-page: 8368
  year: 2020
  ident: 2184_CR9
  publication-title: J Mater Chem B
  doi: 10.1039/d0tb01391a
  contributor:
    fullname: S Liang
– volume: 36
  start-page: 99
  year: 2017
  ident: 2184_CR10
  publication-title: Cytokine Growth Factor Rev
  doi: 10.1016/j.cytogfr.2017.06.003
  contributor:
    fullname: E Cappuzzello
– volume: 235
  start-page: 9291
  year: 2020
  ident: 2184_CR2
  publication-title: J Cell Physiol
  doi: 10.1002/jcp.29827
  contributor:
    fullname: Y Zhang
SSID ssj0061919
Score 2.504244
Snippet Emerging evidence from the numerous clinical trials involving cytokine-induced killer (CIK) cell therapy suggests that its optimization in combination with...
Abstract Emerging evidence from the numerous clinical trials involving cytokine-induced killer (CIK) cell therapy suggests that its optimization in combination...
SourceID doaj
pubmedcentral
proquest
gale
crossref
pubmed
SourceType Open Website
Open Access Repository
Aggregation Database
Index Database
StartPage 388
SubjectTerms Cancer
Cancer therapies
Care and treatment
Cell- and Tissue-Based Therapy - methods
Clinical trials
Cytokine-induced killer (CIK) cell therapy
Cytokine-Induced Killer Cells - metabolism
Cytokines
Cytotoxicity
Dendritic cells
Epigenetics
Graft versus host disease
Humans
Immunotherapies
Immunotherapy
Immunotherapy - methods
Monoclonal antibodies
Neoplasms - drug therapy
Time Factors
Tumors
SummonAdditionalLinks – databaseName: Directory of Open Access Journals
  dbid: DOA
  link: http://sdu.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV1Jb9UwELagB8QFQdkCBYyExAFFjWPHC7fSRSAEF0CCk-V4gapS3lPz3qH_nhk7LzTiwIVrPJHiWTwz8cw3hLwCH-GNZ6ZuVRC16FWqXQBzl50DafdJxvLr4ov6_F2fnCJMzjzqC2vCCjxwYdyh8Ik5xpxAZYtO9Dp2kUPg3WPTpSjopY3cJVPlDIasgJldi4yWhyPDC8AayxFyTlO3CzeU0fr_PpOvOaVlweQ1D3R2l9yZQkd6VD75HrkRh31y69N0OX6f_OANvQLFHekq0eMPHyn-lKelwerqLYWjza3PN3lc1_ATn1MwYAopsbuYpvWM1A2BFpgRuv7ThvmAfDs7_Xr8vp4mJ9S-M2JTdzx0HbhiH00Losho5D6wyFNMPBnlGDgh5x1nXASpGtU2Efx0kAloBGv4Q7I3rIb4mFANjI5OKe2CFiEko33PnVQm8D5EYyryZsdIuy4AGTYnFlrawnYLLLeZ7batyDvk9UyJ4Nb5AYjcTiK3_xJ5RV6gpGzpFJ1N1B5JDdkU3gRW5HWmQCMFgXk39RrAlhDuakF5sKAE4_LL5Z022Mm4RwtJJ4SFrcbll_MyvokFa0NcbZEGYlkO4RuryKOiPPOmORyaUhvYh1qo1YIry5Xh_FeG_tYSx0OzJ_-DjU_J7RYtAmtzzAHZ21xu4zNycwzb59mYfgObiiBG
  priority: 102
  providerName: Directory of Open Access Journals
Title 30 years of CIK cell therapy: recapitulating the key breakthroughs and future perspective
URI https://www.ncbi.nlm.nih.gov/pubmed/34886895
https://www.proquest.com/docview/2611252858
https://search.proquest.com/docview/2608537101
https://pubmed.ncbi.nlm.nih.gov/PMC8662881
https://doaj.org/article/4cf1a11a44004ea4b8e5e3096b825145
Volume 40
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://sdu.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1Lb9QwELbYHhAXxJtAKUZC4oDSXceOH9zapRUIFSEeEnCxHNtpV9Dsqtk99N8z4yTLRty45BCPpcQzn2fGngchL0FHeOOZyQsVRC4qVecuANxl6YDbVS1jd3TxRX38rt-eYJmccsiFSUH7vlocNr8vD5vFRYqtXF366RAnNv10NtcSm-Sy6YRMwDYcXPRu-wWHIHXzmIHiz8Hz00OmjJbTluE9YI5RCcm1ybGXDQcRlhr7S-woplS__99dekdNjUMod3TS6R1yuzcm6VH30XfJjdjcIzfP-uvy--QHn9FrEOWWLms6f_-B4jE97VKurt9Q2OzcarFODbyac3xPAdIUnGT3q-_f01LXBNoVHqGrv4mZD8i305Ov83d530sh96UR67zkoSxBOftoCmBOqk_uA4u8jjWvjXIM1JLzjjMuglQzVcwiaO4ga6ARbMYfkr1m2cTHhGpZ6eiU0i5oEUJttK-4k8oEXoVoTEZeDwtpV13JDJtcDS1txwELq28TB2yRkWNc6y0llrtOL5ZX57ZnuhW-Zo4xJ3DHiU7AB5SRg_dVYeatKDPyHDllu9zRLWjtkdTgX-HdYEZeJQqELTDMuz77AH4JC2CNKPdHlAA3Px4epMH2cG8tuKFgKBYah19sh3EmhrA1cblBGrBuORh0LCOPOuHZ_vQggxlRI7Earcp4BLCRioH3WHjy3zOfklsFIgJDdMw-2VtfbeIzMmnD5iAdUMDz8_HPgwSyP3miJZk
link.rule.ids 230,315,729,782,786,866,887,2106,27933,27934,53800,53802
linkProvider National Library of Medicine
linkToHtml http://sdu.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1Lb9QwELZokYAL70KgUCMhcUDpxrHj2NzK0qpVuxUSRYKT5dhOWUGzq-7uof-eGSdZNuLWa2Ysxfnm4YnnQch78BFOO6bTvPQiFVVZp9aDusvCAtpVLUP76-Jbef5DfTnENjlFXwsTk_ZdNd1v_lztN9NfMbdyfuVGfZ7Y6OtkrCQOyWWjLXIX9DXL-iC9NcAQEsR5Hhm4_hRiP9XXyig5WjC8CUwxLyEGNylOs-EgxFLhhIkN1xQ7-P9vpzcc1TCJcsMrHT265X4ek4fdMZQetOQn5E5onpJ7k-6i_Rn5yTN6A0qwoLOajk9OKf7gp22x1s0nCmbSzqfLOPqrucTnFIwBhfDa_u4m_yyobTxtW5bQ-b-Szufk-9Hhxfg47aYwpK7QYpkW3BcFuHUXdA6wxs7mzrPA61DzWpeWgUOzznLGhZdlVuZZAJ_vZQ08gmV8h2w3sya8JFTJSgVblsp6JbyvtXIVt7LUnlc-aJ2Qjz0AZt422zAxSFHStMgZQM1E5EyekM-I0ZoTG2XHB7PrS9N9XiNczSxjVqCtClbACxSBQ9xWYc2uKBKyhwibtup0re7mQCqIzPBWMSEfIgcqPADtbFe3AFvC1lkDzt0BJyiqG5J7KTKdoVgYCGDhiJkrJL9bk3ElJr81YbZCHjgXczgKsoS8aIVuveledhNSDsRx8FWGFJDC2Ea8k7pXt165R-4fX0zOzNnJ-elr8iBHrcJEH71LtpfXq_CGbC386m1Uzr9BFDkk
linkToPdf http://sdu.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwpV1Lb9QwELZokSouvB-BQo2ExAGliePEcbiVbVdUpVUlQIKT5dhOWbXNRs3uof-eGefBRtzgao-lON88PPY8CHkHNsIUhhVhkts0TMu8CrUFcReZBrTLSrju6uJrfvZDHh5hmZyx1ZcP2jflYr--ut6vF798bGVzbaIhTiw6P51JgU1yWdTYKtoid0Fm42Rw1DslDG6B7-kRg_kPwf-TQ76MFFHL8DUwxNgE7-CE2NGGAyMLiV0mNsyTr-L_t67eMFbTQMoNyzR_8B97ekju98dRetCRPCJ3XP2Y7Jz2D-5PyE8e01sQhpYuKzo7PqF40U-7pK3bjxTUpW4WK98CrL7AcQpKgYKbrS_7DkAt1bWlXekS2vxJ7XxKvs-Pvs0-h303htBkRboKM26zDMy7cUUC8PoK58YyxytX8arINQPDpo3mjKdW5HGexA5svxUV0KQs5s_Idr2s3QtCpSil03kutZWptVUhTcm1yAvLS-uKIiAfBhBU0xXdUN5ZkUJ16ClATnn0VBKQT4jTSIkFs_3A8uZC9b9YpaZimjGdos5yOoUPyBwH_63E3N00C8geoqy67NNR7NWBkOCh4etiQN57ChR8ANvoPn8BtoQltCaUuxNKEFgznR44SfUKo1XgyMJRM5E4_XacxpUYBFe75Rpp4HzM4UjIAvK8Y7xx0wP_BiSfsOTkr0xngBN9OfGe817-88o9snN-OFdfjs9OXpF7CQoWxvsUu2R7dbN2r8lWa9dvvHz-BiTXO6Q
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=30+years+of+CIK+cell+therapy%3A+recapitulating+the+key+breakthroughs+and+future+perspective&rft.jtitle=Journal+of+experimental+%26+clinical+cancer+research&rft.au=Sharma%2C+Amit&rft.au=Schmidt-Wolf%2C+Ingo+G+H&rft.date=2021-12-09&rft.pub=BioMed+Central&rft.issn=1756-9966&rft.volume=40&rft.spage=1&rft_id=info:doi/10.1186%2Fs13046-021-02184-2
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1756-9966&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1756-9966&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1756-9966&client=summon